Kalytera Announces Binding Agreement to Acquire Salzman Group

Hit enter to search or ESC to close

Investors
Contact

Investors
Contact

Media Mentions

DEA Eases Restrictions on CBD Research to Benefit Big Pharma [HighTimes]

By Kalytera December 30, 2015 No Comments

DEA Eases Restrictions on CBD Research to Benefit Big Pharma [HighTimes]

http://www.hightimes.com/read/dea-eases-restrictions-cbd-research-benefit-big-pharma

Get Email Alerts Subscribe

New Website Coming Soon

© 2020 Kalytera Therapeutics, Inc.

Kalytera Announces Binding Agreement to Acquire Salzman Group

Investors
Contact

© 2016 Kalytera Therapeutics, Inc.